Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Hitman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Diabetes|January 24, 2003
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetesAnna L Gloyn, Michael N Weedon, Katharine R Owen, et al.
BMJ Open|November 28, 2023
Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative studyAngeliki Bolou, Zoe Drymoussi, Doris Lanz, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Diabetes|March 1, 2007
Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetesWendy Winckler, Michael N Weedon, Robert R Graham, et al.
Diabetes|August 30, 2008
Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studiesInês Barroso, Jian'an Luan, Eleanor Wheeler, et al.
BMJ Open|March 12, 2022
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative studyChiamaka Esther Amaefule, Zoe Drymoussi, Francisco Jose Gonzalez Carreras, et al.
BMJ Open|May 20, 2020
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA)Chiamaka Esther Amaefule, Angeliki Bolou, Zoe Drymoussi, et al.
Nature Genetics|July 3, 2007
Common variants in WFS1 confer risk of type 2 diabetesManjinder S Sandhu, Michael N Weedon, Katherine A Fawcett, et al.
Journal of Medical Genetics|September 3, 2016
Meta-analysis of genome-wide association studies of HDL cholesterol response to statinsIris Postmus, Helen R Warren, Stella Trompet, et al.
Nature Communications|October 29, 2014
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statinsIris Postmus, Stella Trompet, Harshal A Deshmukh, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Diabetes|January 24, 2003
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetesAnna L Gloyn, Michael N Weedon, Katharine R Owen, et al.
BMJ Open|November 28, 2023
Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative studyAngeliki Bolou, Zoe Drymoussi, Doris Lanz, et al.
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Diabetes|March 1, 2007
Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetesWendy Winckler, Michael N Weedon, Robert R Graham, et al.
Diabetes|August 30, 2008
Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studiesInês Barroso, Jian'an Luan, Eleanor Wheeler, et al.
BMJ Open|March 12, 2022
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative studyChiamaka Esther Amaefule, Zoe Drymoussi, Francisco Jose Gonzalez Carreras, et al.
BMJ Open|May 20, 2020
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA)Chiamaka Esther Amaefule, Angeliki Bolou, Zoe Drymoussi, et al.
Nature Genetics|July 3, 2007
Common variants in WFS1 confer risk of type 2 diabetesManjinder S Sandhu, Michael N Weedon, Katherine A Fawcett, et al.
Journal of Medical Genetics|September 3, 2016
Meta-analysis of genome-wide association studies of HDL cholesterol response to statinsIris Postmus, Helen R Warren, Stella Trompet, et al.
Nature Communications|October 29, 2014
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statinsIris Postmus, Stella Trompet, Harshal A Deshmukh, et al.
Pageof 2